The post Here’s why Michael Saylor and MSTR are facing questions despite Bitcoin’s uptick appeared on BitcoinEthereumNews.com. Key Takeaways What happened to MSTR? It dropped by 4% in a month, even though Bitcoin’s value rose by 3% over the same period.  How are other “Bitcoin treasury” firms doing? Other firms fell far worse – Metaplanet fell by 36%, KindlyMD by 87%, and Semler Scientific by 12%. Michael Saylor’s firm, Strategy (formerly MicroStrategy), has long been hailed as the poster child of corporate Bitcoin [BTC] adoption. Its bold treasury strategy has not only pushed MSTR into the spotlight, but also inspired dozens of other companies to follow a Bitcoin-centric path. And yet, the narrative has somewhat shifted in recent weeks. Strategy and other firms face a decline Despite Bitcoin climbing by 3% over the past month, Strategy’s stock slid by 4%, sparking renewed debate over whether Saylor’s high-stakes, debt-fueled bet on the world’s largest cryptocurrency is as resilient as once believed. While Michael Saylor’s Strategy faced a modest dip, other firms that mimicked its Bitcoin-first playbook are seeing far steeper declines. Japanese hotel operator Metaplanet, for instance, plunged by 27.62% in just a month. Others like healthcare startup KindlyMD, a newcomer to the Bitcoin treasury club, collapsed by 87%. In fact, even medical tech firm Semler Scientific, which joined the trend earlier this year, is down 12% right now.  Not everyone is backing away though.  A persistence of optimism The Swiss National Bank has quietly started purchasing shares of MicroStrategy (MSTR), effectively giving the central bank indirect exposure to Bitcoin without buying the cryptocurrency outright. A lot of the aforementioned companies initially rushed into Bitcoin treasuries when soaring prices, looser regulations, and favorable accounting changes made it attractive to do so. Alas, saturation is now evident. With over 180 public firms holding Bitcoin and controlling roughly 5% of all coins in circulation, some are trading below the value… The post Here’s why Michael Saylor and MSTR are facing questions despite Bitcoin’s uptick appeared on BitcoinEthereumNews.com. Key Takeaways What happened to MSTR? It dropped by 4% in a month, even though Bitcoin’s value rose by 3% over the same period.  How are other “Bitcoin treasury” firms doing? Other firms fell far worse – Metaplanet fell by 36%, KindlyMD by 87%, and Semler Scientific by 12%. Michael Saylor’s firm, Strategy (formerly MicroStrategy), has long been hailed as the poster child of corporate Bitcoin [BTC] adoption. Its bold treasury strategy has not only pushed MSTR into the spotlight, but also inspired dozens of other companies to follow a Bitcoin-centric path. And yet, the narrative has somewhat shifted in recent weeks. Strategy and other firms face a decline Despite Bitcoin climbing by 3% over the past month, Strategy’s stock slid by 4%, sparking renewed debate over whether Saylor’s high-stakes, debt-fueled bet on the world’s largest cryptocurrency is as resilient as once believed. While Michael Saylor’s Strategy faced a modest dip, other firms that mimicked its Bitcoin-first playbook are seeing far steeper declines. Japanese hotel operator Metaplanet, for instance, plunged by 27.62% in just a month. Others like healthcare startup KindlyMD, a newcomer to the Bitcoin treasury club, collapsed by 87%. In fact, even medical tech firm Semler Scientific, which joined the trend earlier this year, is down 12% right now.  Not everyone is backing away though.  A persistence of optimism The Swiss National Bank has quietly started purchasing shares of MicroStrategy (MSTR), effectively giving the central bank indirect exposure to Bitcoin without buying the cryptocurrency outright. A lot of the aforementioned companies initially rushed into Bitcoin treasuries when soaring prices, looser regulations, and favorable accounting changes made it attractive to do so. Alas, saturation is now evident. With over 180 public firms holding Bitcoin and controlling roughly 5% of all coins in circulation, some are trading below the value…

Here’s why Michael Saylor and MSTR are facing questions despite Bitcoin’s uptick

3 min read

Key Takeaways

What happened to MSTR?

It dropped by 4% in a month, even though Bitcoin’s value rose by 3% over the same period. 

How are other “Bitcoin treasury” firms doing?

Other firms fell far worse – Metaplanet fell by 36%, KindlyMD by 87%, and Semler Scientific by 12%.


Michael Saylor’s firm, Strategy (formerly MicroStrategy), has long been hailed as the poster child of corporate Bitcoin [BTC] adoption.

Its bold treasury strategy has not only pushed MSTR into the spotlight, but also inspired dozens of other companies to follow a Bitcoin-centric path.

And yet, the narrative has somewhat shifted in recent weeks.

Strategy and other firms face a decline

Despite Bitcoin climbing by 3% over the past month, Strategy’s stock slid by 4%, sparking renewed debate over whether Saylor’s high-stakes, debt-fueled bet on the world’s largest cryptocurrency is as resilient as once believed.

While Michael Saylor’s Strategy faced a modest dip, other firms that mimicked its Bitcoin-first playbook are seeing far steeper declines.

Japanese hotel operator Metaplanet, for instance, plunged by 27.62% in just a month. Others like healthcare startup KindlyMD, a newcomer to the Bitcoin treasury club, collapsed by 87%.

In fact, even medical tech firm Semler Scientific, which joined the trend earlier this year, is down 12% right now. 

Not everyone is backing away though. 

A persistence of optimism

The Swiss National Bank has quietly started purchasing shares of MicroStrategy (MSTR), effectively giving the central bank indirect exposure to Bitcoin without buying the cryptocurrency outright.

A lot of the aforementioned companies initially rushed into Bitcoin treasuries when soaring prices, looser regulations, and favorable accounting changes made it attractive to do so.

Alas, saturation is now evident.

With over 180 public firms holding Bitcoin and controlling roughly 5% of all coins in circulation, some are trading below the value of their actual crypto reserves.

Therefore, analysts warn that this imbalance could spark investor frustration or even forced liquidations, creating fresh stress points for balance sheets. 

Syalor is not backing down!

And yet, despite everything, Saylor is continuing to double down on his Bitcoin thesis. He added another 3,081 BTC worth roughly $357 million – Pushing Strategy’s total stash to 632,457 BTC. 

The scale of the bet is striking. Especially after Saylor hinted in August that Strategy could aim for 3%–7% of all Bitcoin in circulation.

Nobody knows whether this bold accumulation play will cement Strategy’s place as the ultimate Bitcoin proxy or add more fuel to concerns about overexposure. One thing is clear though – Saylor is not backing down, even as the broader “Bitcoin treasury” trend shows signs of strain.

Next: MemeCore [M] booms 16% as memecoins surge: Will the rally last?

Source: https://ambcrypto.com/heres-why-michael-saylor-and-mstr-are-facing-questions-despite-bitcoins-uptick/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
XRP Ledger Unlocks Permissioned Domains With 91% Validator Backing

XRP Ledger Unlocks Permissioned Domains With 91% Validator Backing

XRP Ledger activated XLS-80 after 91% validator approval, enabling permissioned domains for credential-gated use on the public XRPL. The XRP Ledger has activated
Share
LiveBitcoinNews2026/02/06 13:00
TrendX Taps Trusta AI to Develop Safer and Smarter Web3 Network

TrendX Taps Trusta AI to Develop Safer and Smarter Web3 Network

The purpose of collaboration is to advance the Web3 landscape by combining the decentralized infrastructure of TrendX with AI-led capabilities of Trusta AI.
Share
Blockchainreporter2025/09/18 01:07